Specialized Treatment Early in Psychosis (STEP)

Conditions

Schizophrenia and Disorders With Psychotic Features

What is the purpose of this trial?

The purpose of this study is to understand the effectiveness of a specialized package of phase-specific treatments for individuals in the midst of their first episode of psychosis. The pharmacologic and psychosocial treatments will be delivered within a state public mental health center.



Participation Guidelines

Age:
16 Years - 45 Years
Gender:
Both

Click here for detailed information about who can participate in this trial.


Sponsor:
Yale University
Dates:
March 2006
Last Updated:
September 17, 2013
Study HIC#:
0601001013

Clinicaltrials.gov ID: NCT00309452